Bizarre Patents
Dining Table Having Integral Dishwasher
A space-saving dishwasher, which may be installed within a counter top or table, having a dish-carrying rack that is vertically shiftable through the open top of the dishwasher for facilitating loading and unloading of the dishes.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8067420 | Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein R1 | 11/29/2011 |
| 7989433 | Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists The present invention provides compounds having the following Formula IA and IB, which are useful as MCHR1 antagonists, and includes prodrugs and pharmaceutically acceptable salts thereof: ... | 08/02/2011 |
| 7943658 | Indole indane amide compounds useful as CB2 agonists and method Indole indane amides which are CB2 agonists are provided which have the structure wherein R1, R2, R3, R4 and R5 are as defined herein, which compounds are useful in tre... | 05/17/2011 |
| 7910747 | Phosphonate and phosphinate pyrazolylamide glucokinase activators Pyrazoloamides are provided which are phosphonate and phosphinate glucokinase activators that are useful in treating diabetes and related diseases and have the structure wherein i... | 03/22/2011 |
| 7888504 | Glucokinase activators and methods of using same Compounds are provided which are glucokinase activators and thus are useful in treating diabetes and related diseases and have the structure wherein in the ring represents one or two double bonds; | 02/15/2011 |
| 7884113 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators The invention provides for compounds of formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for t... | 02/08/2011 |
| 7880004 | Met kinase inhibitors The invention is directed to compounds that are useful for the treatment of cancer having the following Formula: ... | 02/01/2011 |
| 7858639 | Bicyclic heterocycles as cannabinoid-1 receptor modulators The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to... | 12/28/2010 |
| 7851622 | Non-basic melanin concentrating hormone receptor-1 antagonists The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compo... | 12/14/2010 |
| 7851489 | Pyridinone compounds The invention is directed to pyridinone compounds useful for modulating Met kinase, having the following structure: and is further directed to pharmaceutical compositions comprising the compound; and methods for treating pr... | 12/14/2010 |
| 7812024 | Modulators of serotonin receptors The present invention provides modulators of serotonin receptors, pharmaceutical compositions containing such modulators and methods for treating various diseases, conditions and disorders associated with modulation of serotonin receptors such as, for example: metab... | 10/12/2010 |
| 7772267 | Bicyclic modulators of androgen receptor function There are provided compounds according to formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions... | 08/10/2010 |
| 7745447 | Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compo... | 06/29/2010 |
| 7732613 | Met kinase inhibitors The present invention is directed to compounds that are useful for treating cancer having one of the following Formulas: ... | 06/08/2010 |
| 7732480 | Bicyclic compounds as modulators of androgen receptor function and method There are disclosed bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example sarcopenia... | 06/08/2010 |
| 7723355 | 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compo... | 05/25/2010 |
| 7709647 | Tetrahydroquinoline cannabinoid receptor modulators The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to... | 05/04/2010 |
| 7696241 | Bicyclic compounds as modulators of androgen receptor function and method The present invention relates to bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for examp... | 04/13/2010 |
| 7635699 | Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods Compounds are provided having the formula (I) wherein X for each occurrence is N or C-A, and R, Y, A and n are as defined herein, which compounds are dipeptidyl peptidase IV inhibitors and as such are useful in treating dia... | 12/22/2009 |
| 7632837 | Bicyclic heterocycles as cannabinoid-1 receptor modulators The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to... | 12/15/2009 |
| 7629342 | Azabicyclic heterocycles as cannabinoid receptor modulators The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to... | 12/08/2009 |
| 7625923 | Bicyclic modulators of androgen receptor function The present invention relates to bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for examp... | 12/01/2009 |
| 7592454 | Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists The present application provides novel compounds according to Formula (I): including all stereoisomers, solvates, prodrug esters and pharmaceutically acceptable salt forms thereof, wherein R1, R4a, R | 09/22/2009 |
| 7589193 | C-aryl glucoside SGLT2 inhibitors and method A compound of the formula I A method is also provided for treating diabetes and related diseases employing the above compound alone or in combination with another therapeutic agent. ... | 09/15/2009 |
| 7589088 | Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods Compounds are provided having the formula (I) wherein R, B, X and Y are as defined herein. ... | 09/15/2009 |
| 7572808 | Triazolopyridine cannabinoid receptor 1 antagonists The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according t... | 08/11/2009 |
| 7566784 | Bicyclic heterocycles as kinase inhibitors The compounds of the instant invention can be used as anticancer agents. More specifically, the invention comprises a compound having Formula I or II, ... | 07/28/2009 |
| 7557143 | Thyroid receptor ligands Thyroid receptor ligands are provided which have the general formula I wherein: R1 is R2... | 07/07/2009 |
| 7553836 | Melanin concentrating hormone receptor-1 antagonists The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein R1a, R1b | 06/30/2009 |
| 7547782 | Met kinase inhibitors The present invention is directed to compounds having the formula I or II: including salts thereof, and methods for using them for the treatment of cancer. ... | 06/16/2009 |
| 7517991 | N-sulfonylpiperidine cannabinoid receptor 1 antagonists The present application describes compounds according to Formula I, wherein R1, R2, R3, R4, X and Y are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one ... | 04/14/2009 |
| 7517900 | Pyrazole derivatives as cannabinoid receptor modulators The present application describes compounds according to Formula I, wherein A, B, E, R1, R2, R3, R4, Y and Z are described herein. Additionally, the present application describes pharmaceutical compositions comprising at l... | 04/14/2009 |
| 7501416 | Quinoxaline compounds and methods of using them The present invention generally relates to quinoxaline compounds having Formula 1 or Formula 2 wherein the variables are as defined herein, and methods of using them. ... | 03/10/2009 |
| 7470713 | Imidazole based kinase inhibitors The present invention provides compounds having formula I and their use for the treatment of cancer. ... | 12/30/2008 |
| 7470693 | Oxalamide derivatives as kinase inhibitors The invention is directed to compounds having the following Formula I: and methods of using them for the treatment of proliferative diseases. ... | 12/30/2008 |
| 7459460 | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators Trisubstituted heteroaromatic compounds having the structure are provided, wherein X is C or N; A and B are each independently CH or N, with the proviso that A and B canno... | 12/02/2008 |
| 7459562 | Monocyclic heterocycles as kinase inhibitors The present invention is directed to compounds having the formula and methods for using them for the treatment of cancer. ... | 12/02/2008 |
| 7456188 | C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators The present application describes compounds according to Formula I, wherein Q, R1, R2 and X are described herein, that are useful as Estrogen Receptor Beta (ERĪ²) modulators. Additionally, the present application describes pharmaceutical compos... | 11/25/2008 |
| 7452892 | Triazolopyrimidine cannabinoid receptor 1 antagonists The present application describes compounds according to both Formulas I and II, pharmaceutical compositions comprising at least one compound according to either Formula I or II and optionally one or more additional therapeutic agents, and methods of treatment using... | 11/18/2008 |
| 7439246 | Fused heterocyclic kinase inhibitors In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful... | 10/21/2008 |
